|
Fusion gene ID: 41374 |
FusionGeneSummary for VAV2_EFNB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: VAV2_EFNB1 | Fusion gene ID: 41374 | Hgene | Tgene | Gene symbol | VAV2 | EFNB1 | Gene ID | 7410 | 1947 |
Gene name | vav guanine nucleotide exchange factor 2 | ephrin B1 | |
Synonyms | VAV-2 | CFND|CFNS|EFB1|EFL3|EPLG2|Elk-L|LERK2 | |
Cytomap | 9q34.2 | Xq13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | guanine nucleotide exchange factor VAV2vav 2 guanine nucleotide exchange factorvav 2 oncogene | ephrin-B1ELK ligandeph-related receptor tyrosine kinase ligand 2 | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P52735 | P98172 | |
Ensembl transtripts involved in fusion gene | ENST00000406606, ENST00000371850, ENST00000371851, ENST00000486113, | ENST00000204961, | |
Fusion gene scores | * DoF score | 11 X 9 X 9=891 | 2 X 2 X 1=4 |
# samples | 14 | 2 | |
** MAII score | log2(14/891*10)=-2.66999860457696 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/4*10)=2.32192809488736 | |
Context | PubMed: VAV2 [Title/Abstract] AND EFNB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BF820909 | VAV2 | chr9 | 136633110 | + | EFNB1 | chrX | 68060458 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000406606 | ENST00000204961 | VAV2 | chr9 | 136633110 | + | EFNB1 | chrX | 68060458 | - |
intron-3CDS | ENST00000371850 | ENST00000204961 | VAV2 | chr9 | 136633110 | + | EFNB1 | chrX | 68060458 | - |
intron-3CDS | ENST00000371851 | ENST00000204961 | VAV2 | chr9 | 136633110 | + | EFNB1 | chrX | 68060458 | - |
intron-3CDS | ENST00000486113 | ENST00000204961 | VAV2 | chr9 | 136633110 | + | EFNB1 | chrX | 68060458 | - |
Top |
FusionProtFeatures for VAV2_EFNB1 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
VAV2 | EFNB1 |
Binds to the receptor tyrosine kinases EPHB1 and EPHA1.Binds to, and induce the collapse of, commissural axons/growthcones in vitro. May play a role in constraining the orientation oflongitudinally projecting axons (By similarity). {ECO:0000250}. Cell surface transmembrane ligand for Eph receptors, afamily of receptor tyrosine kinases which are crucial formigration, repulsion and adhesion during neuronal, vascular andepithelial development. Binds promiscuously Eph receptors residingon adjacent cells, leading to contact-dependent bidirectionalsignaling into neighboring cells. The signaling pathway downstreamof the receptor is referred to as forward signaling while thesignaling pathway downstream of the ephrin ligand is referred toas reverse signaling. Binds to the receptor tyrosine kinases EPHB3(preferred), EPHB1 and EPHA1. Binds to, and induce the collapseof, commissural axons/growth cones in vitro. May play a role inconstraining the orientation of longitudinally projecting axons(By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for VAV2_EFNB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for VAV2_EFNB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for VAV2_EFNB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for VAV2_EFNB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | EFNB1 | C0220767 | Craniofrontonasal dysplasia | 3 | CTD_human;ORPHANET;UNIPROT |
Tgene | EFNB1 | C0010278 | Craniosynostosis | 1 | CTD_human;HPO |
Tgene | EFNB1 | C0020534 | Orbital separation excessive | 1 | CTD_human;HPO |
Tgene | EFNB1 | C0021368 | Inflammation | 1 | CTD_human |
Tgene | EFNB1 | C0028754 | Obesity | 1 | CTD_human |
Tgene | EFNB1 | C1876203 | Frontonasal dysplasia | 1 | CTD_human |